Atlas Trials

Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis

Clinical trial NCT00004317 · RECRUITING

Trial details

NCT number
NCT00004317
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Toxoplasmosis
Start date
2000-07-01
Primary completion
2030-12-01
Enrollment
600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.